Login to Your Account

'A New Golden Age'

Third Rock Raises $516M, Seeks Early Stage Firms

By Catherine Shaffer
Staff Writer

Monday, March 25, 2013

Third Rock Ventures raised its third fund of $516 million, continuing with its mission to launch and invest in companies developing disruptive technologies in the field of health care. "We look for areas of science and translational medicine that have become ripe for a breakthrough fundamental advance," Third Rock partner Alexis Borisy told BioWorld Today.

The Boston-based venture firm debuted in 2007 with a $386 million inaugural fund. It followed up with a $426 million second fund in 2010. (See BioWorld Today, Sept. 18, 2007, and April 19, 2010.)

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription